Belinostat in Treating Patients With Myelodysplastic Syndromes

Summary

This phase II trial is studying how well belinostat works in treating patients with myelodysplastic syndromes. Belinostat may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the cancer.

Timeline

Start

2006-05

Primary completion

2010-12

Completion

2010-12

Drugs

Indications